Cargando…

Unravelling the complex drug–drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein

Drug–drug interactions (DDIs) and associated toxicity from cardiovascular drugs represents a major problem for effective co-administration of cardiovascular therapeutics. A significant amount of drug toxicity from DDIs occurs because of drug interactions and multiple cardiovascular drug binding to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ledwitch, Kaitlyn V., Barnes, Robert W., Roberts, Arthur G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2016
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793304/ https://www.ncbi.nlm.nih.gov/pubmed/26823559 http://dx.doi.org/10.1042/BSR20150317

Ejemplares similares

Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring
por: Englund, Gunilla, et al.
Publicado: (2004)

Pharmacokinetic Drug‐Drug Interaction Study of Omecamtiv Mecarbil With Amiodarone and Digoxin in Healthy Subjects
por: Trivedi, Ashit, et al.
Publicado: (2021)

Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects
por: Chong, Edward, et al.
Publicado: (2014)

Verapamil as an Adjuvant Treatment for Drug-Resistant Epilepsy
por: Lakshmikanthcharan, S., et al.
Publicado: (2018)

Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor
por: Mendell, Jeanne, et al.
Publicado: (2013)

Mechanisms and the clinical relevance of complex drug–drug interactions
por: Roberts, Arthur G, et al.
Publicado: (2018)

No Effect of Digoxin on Rosuvastatin Pharmacokinetics in Healthy Subjects: Utility of Oita Combination for Clinical Drug–Drug Interaction Study
por: Otani, Naoyuki, et al.
Publicado: (2019)

Verapamil and Rifampin Effect on P-Glycoprotein Expression in Hepatocellular Carcinoma
por: Jalali, Amir, et al.
Publicado: (2014)

Lack of effect of ezogabine/retigabine on the pharmacokinetics of digoxin in healthy individuals: results from a drug–drug interaction study
por: Tompson, Debra J, et al.
Publicado: (2014)

A Mechanistic, Enantioselective, Physiologically Based Pharmacokinetic Model of Verapamil and Norverapamil, Built and Evaluated for Drug–Drug Interaction Studies
por: Hanke, Nina, et al.
Publicado: (2020)

Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels
por: Veiga-Matos, Jéssica, et al.
Publicado: (2023)

A possible interaction between linezolid and digoxin: A case report of therapeutic drug monitoring
por: Yulin, Zhu, et al.
Publicado: (2020)

Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects
por: Yamazaki, Takao, et al.
Publicado: (2016)

Evaluation of Potential Drug‐Drug Interaction Risk of Pexidartinib With Substrates of Cytochrome P450 and P‐Glycoprotein
por: Zahir, Hamim, et al.
Publicado: (2020)

P‐Glycoprotein Mediated Drug Interactions in Animals and Humans with Cancer
por: Mealey, K.L., et al.
Publicado: (2015)

Induction of P-glycoprotein expression and activity by Aconitum alkaloids: Implication for clinical drug–drug interactions
por: Wu, Jinjun, et al.
Publicado: (2016)

P-glycoprotein transporter in drug development
por: Prachayasittikul, Veda, et al.
Publicado: (2016)

Drug-Induced Conformational Dynamics of P-Glycoprotein Underlies the Transport of Camptothecin Analogs
por: Mensah, Gershon A. K., et al.
Publicado: (2023)

P-glycoprotein- and organic anion-transporting polypeptide-mediated transport of periplocin may lead to drug–herb/drug–drug interactions
por: Liang, Sheng, et al.
Publicado: (2014)

Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies
por: Elmeliegy, Mohamed, et al.
Publicado: (2020)

Evaluation of the Potency of Anti-HIV and Anti-HCV Drugs to Inhibit P-Glycoprotein Mediated Efflux of Digoxin in Caco-2 Cell Line and Human Precision-Cut Intestinal Slices
por: Huličiak, Martin, et al.
Publicado: (2022)

P-glycoprotein Inhibition for Optimal Drug Delivery
por: Amin, Md. Lutful
Publicado: (2013)

Evaluating the regulation of transporter proteins and P-glycoprotein in rats with cholestasis and its implication for digoxin clearance
por: Giroux, Parker, et al.
Publicado: (2022)

Pharmacokinetic Evaluation of a Drug Transporter Cocktail Consisting of Digoxin, Furosemide, Metformin, and Rosuvastatin
por: Stopfer, P, et al.
Publicado: (2016)

Therapeutic drug monitoring on the use of transplacental digoxin in fetal tachyarrhythmia: a case report
por: Jeong, Sae Im, et al.
Publicado: (2022)

Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance.
por: Sakata, K., et al.
Publicado: (1991)

Drug–Drug–Gene Interactions in Cardiovascular Medicine
por: Asiimwe, Innocent G, et al.
Publicado: (2022)

The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation
por: Senarathna, S M D K Ganga, et al.
Publicado: (2016)

Pharmacokinetic Modeling of (R)-[(11)C]verapamil to Measure the P-Glycoprotein Function in Nonhuman Primates
por: García-Varela, Lara, et al.
Publicado: (2020)

Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs
por: Kono, Yusuke, et al.
Publicado: (2021)

Circumvention of drug resistance in human non-small cell lung cancer in vitro by verapamil.
por: Merry, S., et al.
Publicado: (1987)

Losartan Potassium and Verapamil Hydrochloride Compound Transdermal Drug Delivery System: Formulation and Characterization
por: Chen, Yu-si, et al.
Publicado: (2022)

Factors Governing P-Glycoprotein-Mediated Drug–Drug Interactions at the Blood–Brain Barrier Measured with Positron Emission Tomography
por: Wanek, Thomas, et al.
Publicado: (2015)

Microtubule-targeting anticancer drug eribulin induces drug efflux transporter P-glycoprotein
por: Nabekura, Tomohiro, et al.
Publicado: (2020)

P glycoprotein (P-gp) and drug resistance--time for reappraisal?
por: Kaye, S. B.
Publicado: (1993)

Selective modulation of P-glycoprotein-mediated drug resistance
por: Bebawy, M, et al.
Publicado: (2001)

P-Glycoprotein and Drug Resistance in Systemic Autoimmune Diseases
por: Picchianti-Diamanti, Andrea, et al.
Publicado: (2014)

Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network
por: Lin, Yubi, et al.
Publicado: (2017)

Unraveling the Role of Drug-Lipid Interactions in NSAIDs-Induced Cardiotoxicity
por: Pereira-Leite, Catarina, et al.
Publicado: (2020)

The Novel Anticancer Drug KRN5500 Interacts with, but is Hardly Transported by, Human P‐Glycoprotein
por: Takara, Kohji, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_989k0r3k5ij8sbpshusdker42l